DaShenLin Pharmaceutical Group Co., Ltd.SSE: 603233

Announcement on Convening the 2026 Semi-annual Performance Briefing

· Issued by DaShenLin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

DaShenLin Pharmaceutical Group Co., Ltd. has announced a semi-annual performance briefing for investors. It will be held at the Shanghai Stock Exchange Roadshow Center and will be conducted online. Investors can submit questions in advance through the Roadshow Center's website or via email.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

DaShenLin Pharmaceutical Group Co., Ltd. on 6ix

Earlier from DaShenLin Pharmaceutical

Later from DaShenLin Pharmaceutical

All DaShenLin Pharmaceutical news releases